The FGFR1(8p12)Gene Rearrangement Fish Cancer Screening Test is a genetic test used to detect rearrangements in the FGFR1 gene, which may be associated with certain types of cancer.

The test is performed using a technique called fluorescence in situ hybridization (FISH). This involves using special probes that attach to specific DNA sequences on chromosome 8 and then using fluorescent imaging to visualize any rearrangements in the FGFR1 gene.

Rearrangements in the FGFR1 gene have been associated with several types of cancer, including breast cancer, lung cancer, and leukemia.

The test may be recommended for individuals who have a family history of the types of cancer associated with FGFR1 gene rearrangements or who have other risk factors for these types of cancer.

The test is available at many medical centers and hospitals in Delhi that offer genetic testing services. It is important to consult with a doctor or genetic counselor to determine if the test is appropriate for you and where it can be obtained.

Coverage for the test may vary depending on the insurance provider and the specific policy. It is important to check with the insurance company to determine if the test is covered and what the out-of-pocket costs may be.

The turnaround time for the test results may vary depending on the laboratory where the test is performed. However, the test results are typically available within a few days to a week.

If the test results show a rearrangement in the FGFR1 gene, further testing and evaluation may be recommended by a doctor or genetic counselor. Treatment options will depend on the type and stage of cancer.

No, the FGFR1(8p12)Gene Rearrangement Fish Cancer Screening Test is not the only way to detect these types of cancer. Other tests, such as imaging tests or tissue biopsies, may also be used to diagnose these types of cancer.

The FGFR1(8p12)Gene Rearrangement Fish Cancer Screening Test is a highly accurate test with a low rate of false positives and false negatives. However, no test is 100% accurate, and further testing and evaluation may be necessary to confirm a diagnosis.